Segantii Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Segantii Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,000	Closed	-$1.54M	–	334
2023 Q1	$1.54M	Hold	150,000	–	–	0.05%	141
2022 Q4	$1.51M	Hold	150,000	–	–	0.06%	140
2022 Q3	$1.48M	Hold	150,000	–	–	0.04%	162
2022 Q2	$1.46K	Hold	150,000	–	–	0.04%	156
2022 Q1	$1.46M	Hold	150,000	–	–	0.04%	179
2021 Q4	$1.45M	Hold	150,000	–	–	0.04%	182
2021 Q3	$1.48M	Buy	+150,000	New	+$1.46M	0.05%	144

Segantii Capital Management's ORIA Position: Q2 2023 in Review

Segantii Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 150,000 shares — an estimated $1.54M sold.

Segantii Capital Management first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $1.54M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Segantii Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Segantii Capital Management sold 150,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.54M.
Segantii Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Segantii Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.54M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Segantii Capital Management's 13F filing for Q2 2023, filed 2 Aug 2023.